Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy

Neurology
P CorciaY Bacq

Abstract

A 57-year-old man with chronic inflammatory demyelinating polyneuropathy associated with hepatitis C virus infection was treated successfully with the combination of peginterferon-alpha-2b and ribavirin. Viral eradication was confirmed during the 4th week of treatment and was followed 3 weeks later by neurologic improvement. The patient resumed normal activity 1 year after the therapy was completed.

Citations

Jun 3, 2010·Journal of Clinical Neuromuscular Disease·Russell L ChinNorman Latov
May 14, 2005·Current Opinion in Neurology·Hubertus KöllerHans-Peter Hartung
Sep 22, 2007·Current Opinion in Neurology·Marcos R G de Freitas
May 6, 2010·Expert Review of Clinical Immunology·Eduardo A De Sousa
Jul 13, 2005·Acta Neurologica Scandinavica·J Finsterer
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S BoukhrisJ-M Vallat
Oct 31, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R HöftbergerH Budka
Oct 2, 2020·Der Nervenarzt·Felix KleefeldUNKNOWN Deutsche Gesellschaft für Neuro-AIDS und Neuro-Infektiologie (DGNANI)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.